MedTrace Logo

Drug-Drug Interaction of Clomipramine HCl and Sildenafil Citrate in Healthy Males

NCT02028598 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-09-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and pharmacokinetics/pharmacodynamics of co-administration of Clomipramine HCl 15mg and Sildenafil citrate 100mg compared to the effects after single oral administration in Korean healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

Treatment 1

An oral single dose administration

DRUG

Treatment 2

An oral single dose administration

DRUG

Treatment 3

Co-administration of oral single doses

Sponsors & Collaborators

  • Symyoo

    collaborator INDUSTRY

  • CTC Bio, Inc.

    lead INDUSTRY

Principal Investigators

  • Yun Hi Kang, M.D. · Yangji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02028598 on ClinicalTrials.gov